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Stimulation of Dengue Virus Replication in Cultured Aedes albopictus (C6/36) Mosquito Cells
by the Antifungal Imidazoles Ketoconazole and Miconazole
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Replication of dengue type 3 virus in Aedes albopictus C6/36 cells was enhanced more than 50-fold by addition of the
antifungal imidazole derivative ketoconazole within the first 4 h of infection. The stimulatory effect was reflected in the yield
of infectious virus and in levels of viral RNA and protein synthesis. Enhanced yields were observed also for other flaviviruses,
including dengue type 2 virus and Murray Valley encephalitis virus. Increased yields of dengue type 3 virus were not observed
in African green monkey kidney (Vero) cells, human monocytic (U-937) cells, or cells of the mosquito Toxorhynchites
amboinensis (TRA-171). © 2000 Academic Press
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fDengue viruses are the causative agents of dengue
fever and dengue hemorrhagic fever/shock syndrome. In
recent years, increases in human population movements
and vector (Aedes aegypti) density have resulted in a
greatly increased frequency and severity of epidemics
due to dengue viruses (1). A safe and effective vaccine
against the dengue viruses is as yet unavailable despite
considerable efforts over the years (1). Dengue viruses
exist as four serotypes, each composed of a multiplicity
of genetic subtypes (2–4). The viruses have been iso-
lated both from human serum and from mosquito pools.
Prior to virus characterization, it is common to amplify
virus isolates from both sources in cultured Aedes al-
bopictus (clone C6/36) cells, which are highly suscepti-
ble to flavivirus infection (5). We have observed that
dengue type 3 virus (DEN-3) reaches much higher titers
in infected C6/36 cells when the antifungal agent keto-
conazole (KTZ), an imidazole derivative, is present. Due
to the potential utility for other investigations on dengue
virus where high yield is required, we have explored this
observation further.
DEN-3 strains used in the following studies were,
unless otherwise indicated, human clinical isolates from
Indonesia (6) that had been passaged once in each of A.
aegypti and Toxorhynchites amboinensis mosquitoes
and amplified three times in A. albopictus (C6/36) cells
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1(7). C6/36 cells were from the American Type Culture
Collection (ATCC) and were maintained between pas-
sage levels 122 and 142 in Eagle’s minimal essential
medium (EMEM) plus nonessential amino acids and 10%
fetal calf serum (FCS).
The effect of a range of KTZ concentrations (0, 1, 3, 5,
7, 10, and 20 mg/ml) on DEN-3 yield from infected C6/36
cells is shown in Fig. 1A. In this experiment cell mono-
layers were infected with DEN-3 isolate 1153 (m.o.i.
;0.5) and washed after adsorption (1 h) and incubation
continued at 28°C in medium containing KTZ at the
indicated concentrations. At 72 h postinfection (p.i.), su-
pernatant samples were collected for determination of
extracellular virus (EV) titers on African green monkey
kidney (Vero) cells and on C6/36 cells. KTZ added to
infected C6/36 cells at concentrations from 3 to 10 mg/ml
ncreased virus yields as measured by plaque assays on
ero cells and infectious focus formation on C6/36 cells
Fig. 1A). Titers measured on Vero cells were increased
rom 5 3 105 to 107 PFU/ml (i.e., 20-fold). Titers measured
on C6/36 cells as focus-forming units (FFU) per milliliter
were 2- to 8-fold lower than Vero titers but were in-
creased 10- to 70-fold (Fig. 1A). KTZ concentrations of 20
mg/ml or greater were cytopathic for C6/36 cells and
virus titers were reduced accordingly. A KTZ concentra-
tion of 5 mg/ml (approximately 1025 M) was chosen for
use in subsequent studies; this concentration is 103–104
times higher than that required to inhibit fungal growth
(5 3 1029 M for 50% inhibition) (8).
Three other human clinical isolates of DEN-3 (isolates
047, 1084, and 1239) (7), as well as the highly mouse-
dapted DEN-3 prototype strain H87 (9), also showed
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2 RAPID COMMUNICATIONsimilar increases in virus yields in infection of KTZ-
treated C6/36 cells (Table 1; data not shown).
The effect of KTZ on the yields of seven flaviviruses
was compared. The following viruses were investigated:
DEN-3 (H87 prototype), DEN-3 (strain 1153), dengue se-
FIG. 1. Effect of KTZ and other antifungal compounds on DEN-3 titers
in C6/36 cells. (A) C6/36 (1 3 106) cells in 35-mm dishes were infected
with DEN-3 (isolate 1153; m.o.i. ;0.5) for 1 h and washed twice with
PBS, and growth medium with KTZ was added. EV samples were taken
at 72 h p.i. Virus titers were assayed by plaque formation on Vero cells
(open circles) or as FFU on C6/36 cells (solid circles). Plaque assays on
Vero cells were performed as described (20). For determination of FFU
on C6/36 cells, monolayers (30–50% confluent) in 48-well trays (Costar)
were infected with 50 ml of virus from 10-fold serial dilutions in Hank’s
alanced salts solution (HBSS, pH 8, bovine serum albumin added to 1
g/ml). Cells were overlaid with EMEM containing 8% FCS and 1%
arboxymethyl-cellulose and incubated for 4 days at 30°C in a humid-
fied atmosphere (5% CO2/95% air). Foci of infection were detected by
immunofluorescence assay using anti-DEN-3 hyperimmune ascitic
fluid and FITC-conjugated anti-mouse IgG (Silenus) after cell monolay-
ers were fixed with an acetone:methanol mixture (1:1). (B) C6/36 cell
monolayers (2 3 105 cells) in 24-well trays (Nunc) were infected with
irus (m.o.i. ;0.5) and incubated for 1 h. Monolayers were washed
wice with HBSS (pH 8.0). Normal growth medium or medium contain-
ng KTZ (open squares), miconazole (open circles), or fluconazole (solid
ircles) was then added to cells. EV titers at 72 h p.i. were determined
y plaque assays on Vero cells. KTZ (Janssen Pharmaceutical, Turn-
outseweg, Beerse, Belgium) and fluconazole (Pfizer Australia) were
issolved to 10 mg/ml in 0.05 N HCl; miconazole (Sigma) was dissolved
o 3 mg/ml in 50% ethanol.rotype 2 virus (DEN-2; strain New Guinea C), DEN-2
(PUO-218), Murray Valley encephalitis virus (MVE; proto- atype strain MVE-1-51), MVE (BH 3479), and yellow fever
virus (YFV; 17D vaccine strain). All working stocks were
supernatants collected from infected C6/36 cells. C6/36
cells were infected at an m.o.i. of 0.1–1.0 and EV titers at
24 h were determined by plaque titration on Vero cell
monolayers (Table 1). Enhancement of virus yield was
consistently greater for the DEN-3 isolates (27- to 153-
fold) than for the two DEN-2 isolates (10- to 16-fold). For
MVE, enhancement for both isolates (5-fold) was less
than for dengue virus but was consistently greater than
for YFV-17D where enhancement, if it occurred at all, was
low (see below).
Immunofluorescence assays performed for each virus
at 24 h p.i. in this experiment showed that the percentage
of infected cells was not increased by KTZ (see below).
These results also suggest that the differences in en-
hancement of virus production between different flavivi-
ruses are not the result of different passage histories as
the pairs of DEN-3, DEN-2, and MVE strains showing
enhanced yields in the above study differed significantly
from one another in passage histories. A second exper-
iment using the same viruses gave results similar to
those presented in Table 1. In this experiment, the levels
of enhancement in EV titers (at 24 h p.i.) for C6/36 cells
infected with DEN-3 (H87), DEN-3 (1153), DEN-2 (NGC),
DEN-2 (PUO-218), MVE (BH 3479), and YFV (17 D) were
50-, 95-, 14-, 11-, 8-, and 6-fold respectively. A similar
pattern of results was obtained using 48-h EV titers (data
not shown).
The effect of KTZ on DEN-3 (isolate 1153) growth in
other cell lines including Vero, U-937 cells, and TRA-171
commonly used in studies on dengue viruses was ex-
amined. TRA-171 cells, from larvae of T. amboinensis
mosquitoes, were obtained from the ATCC and were
maintained at 28°C in MM/VP12 medium plus 5% FCS
(10). At 24 h after infection with DEN-3, TRA-171 cells
showed EV titers of 105 PFU/ml in the absence of KTZ,
indicating more rapid growth than in C6/36 cells (,103
PFU/ml at 24 h p.i.). However, there was no increase in
EV titers at 24 h p.i. in the presence of 1, 5, 10, and 50
mg/ml of KTZ (data not shown). In Vero cells maintained
in M199 medium plus 5% FCS there was no increase in
EV titers on incubation with 0.01 to 10 mg/ml KTZ. Similar
esults were obtained in human monocytic U-937 cells,
btained from the ATCC and maintained in RPMI plus
0% FCS, when incubated with KTZ (5 mg/ml). Thus of the
our cell lines examined (two vertebrate and two inver-
ebrate), only C6/36 cells showed enhanced DEN-3 titers
n the presence of KTZ.
The effect of a range of chemical compounds related
o KTZ, antifungal or non-antifungal, on DEN-3 replication
as examined next. Figure 1B shows the results ob-
ained with the antifungal KTZ, miconazole (an imidazole
erivative), and fluconazole (a triazole derivative). KTZ (5mg/ml) and miconazole (10 mg/ml) stimulated titers 20-
nd 10-fold, respectively, at 72 h p.i., peak titers were
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3RAPID COMMUNICATIONobtained at 7–10 mg/ml for miconazole (Fig. 1B). Neither
luconazole (5, 10, or 20 mg/ml) nor another antifungal
riazole derivative, itraconazole (5, 10, or 20 mg/ml; data
not shown), increased virus yield. Imidazole, which does
not inhibit fungal growth at 5 and 10 mg/ml, did not
enhance yield at 48 or 72 h p.i. (data not shown). Since
only KTZ and miconazole, both imidazole derivatives,
increased virus titers we conclude that the chemical
nature of the agent, rather than its antifungal properties,
was responsible for its ability to increase DEN-3 titers in
C6/36 cells.
To further characterize the stimulatory effects of KTZ,
cell-associated virus (CAV) titers, the length of the latent
period, and specific infectivity for C6/36 cells were de-
termined using DEN-3 isolate 1153. CAV titers were de-
termined by scraping infected cells, washed twice with
PBS, into medium and lysing by three cycles of freeze–
thawing. Comparisons of CAV titers in C6/36 cells at 24
and 48 h p.i. with and without KTZ treatment showed an
11-fold increase at both time points, consistent with the
increases seen in virus released into the medium over
1 h at the same time points (data not shown).
The latent period of dengue virus replication in C6/36
cells was determined by assaying EV titers between 16
and 24 h p.i. at 2-h intervals. In untreated C6/36 cells the
length of the latent period was 22 h. In cells treated with
KTZ the length of the latent period was reduced to 20 h
(data not shown).
To determine whether KTZ increased the specific in-
fectivity of DEN-3 virus for C6/36 cells, monolayers in
48-well trays were inoculated in duplicate with isolate
1153 (50 FFU per well, 2 3 105 cells). After adsorption,
iquid overlay (growth medium plus 1% carboxymethyl-
ellulose) was added with or without KTZ (5 mg/ml). Cells
were incubated for 4 days at 28°C and examined after
immunofluorescence staining. There was no significant
difference in numbers of foci in the presence or in the
absence of KTZ (data not shown). Foci were significantly
larger in KTZ-treated cells than in untreated cells. We
T
Effect of Ketoconazole on F
DEN-3 DEN
H87 1153 NGC
2KTZ 30 3.6 3 102 3.4 3 103
1KTZ 800 5.5 3 105 3.3 3 104
a Infection of C6/36 (2 3 105) cells with DEN-3, DEN-2, MVE, and YFV
our after addition of virus, cells were washed twice with Hanks’ balan
was added. EV titers at 24 h p.i. were determined by plaque titration oconclude that the increased titers of infectious DEN-3
virus in KTZ-treated C6/36 cells reflect an increase in therate of virus replication rather than an increase in the
percentage of initially infected C6/36 cells.
To ascertain whether KTZ acts at a defined time in the
viral growth cycle, effects of KTZ addition at various
times postinfection on virus yield were determined.
C6/36 cells were infected with DEN-3 (strain 1153, m.o.i.
;1) in normal growth medium. At 1, 4, 8, and 12 h p.i.
growth medium was replaced with fresh medium con-
taining KTZ (5 mg/ml) and incubation continued. Virus
titers at 24 h p.i. were determined by plaque formation on
Vero cell monolayers. Enhancement in yield of 50- and
55-fold was observed if KTZ was added at 1 and 4 h p.i.,
respectively, but little increase in EV titers at 24 h was
observed if the addition of KTZ was delayed until 8 or
12 h p.i. (4- and 2-fold increases, respectively). Preincu-
bation of C6/36 cells for 24 h with KTZ (5 mg/ml) followed
y its removal prior to infection resulted in no increase in
irus titers. Taken together, the above results indicate
hat to achieve maximal enhancement, KTZ should be
dded to C6/36 cells before the first 4 h of infection have
lapsed and be continuously present from that time. The
bove results suggest that KTZ stimulation of virus rep-
ication occurred after entry and uptake into C6/36 cells
nd thus that KTZ may act on viral protein or RNA syn-
hesis.
Stimulatory effects of KTZ on viral protein synthesis
ere examined by radio-immunoprecipitation. C6/36
ells were infected with DEN-3 (m.o.i. ;1) and incubated
ith or without KTZ. Cells were starved of methionine for
0 min from 24 h p.i. and then labeled with [35S]methi-
onine for 3.5 h. Labeled viral proteins were immunopre-
cipitated from cell lysates with anti-DEN-3 hyperimmune
ascitic fluid. DEN-3-specific proteins were examined by
SDS–PAGE and fluorography as described (11). As
shown in Fig. 2A, the profile of DEN-3-specific proteins,
which included those of 70 (NS3), 58 (E), 44 (NS1), 22
(prM), and 16 kDa (NS2B, anchC), was not changed by
KTZ treatment, but KTZ increased the amounts of DEN-
3-specific proteins significantly at 24.5–28 h p.i. Viral
us Yield from C6/36 Cellsa
titer (PFU/ml)
MVE
YF
17DO-218 MVE-1-51 BH3479
3 104 1 3 103 1.2 3 104 1.2 3 103
3 105 5 3 103 5.9 3 104 1.6 3 103
was performed in parallel in 24-well trays using an m.o.i. of 0.1–1. One
lt solution, and growth medium with or without 5 mg/ml ketoconazole
cell monolayers.ABLE 1
lavivir
EV
-2
PU
2.0
3.3
strainsprotein synthesis was also examined in DEN-2 virus-
infected C6/36 cells; there was a twofold increase in viral
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4 RAPID COMMUNICATIONproteins detectable by radioimmunoprecipitation at
24.5–28 h p.i. in KTZ-treated cells compared with un-
treated cells (data not shown). This increase in viral
FIG. 2. Effect of KTZ on DEN-3 virus protein and RNA synthesis in
C6/36 cells. (A) C6/36 cells (1 3 106 in 35-mm dish) were infected with
DEN-3 (isolate 1153, m.o.i. ;1) for 1 h, washed twice with PBS, and
incubated with growth medium with (1K) or without KTZ (2K). At 24 h
p.i., culture fluids were replaced with labeling medium (EMEM without
methionine). After 30 min, cells were metabolically labeled by incuba-
tion for 3.5 h in labeling medium (0.5 ml) plus 50 mCi [35S]methionine
(PRO-MIX 35S cell labeling mix, Amersham). Lysis buffer [1% Nonidet-
P40, 50 mM Tris (pH 7.5), 150 mM NaCl, 2 mM EDTA, 20 mg/ml PMSF]
as added to cells, and lysates were centrifuged (3000 g, 5 min) to
emove nuclei. DEN-3 proteins were immunoprecipitated from the cell
ysates using anti-DEN-3 hyperimmune ascitic fluid and Protein
–Sepharose CL-4B (Pharmacia) and examined by SDS–PAGE and
luorography in a 10% polyacrylamide gel. MI, mock-infected control.
arkers of molecular mass are shown on the left. (B) C6/36 cells (1 3
06 in 35-mm dish) were infected with DEN-3 (isolate 1153, m.o.i. ;1)
or 1 h, washed twice with PBS, and incubated with growth medium
ith (solid circles) or without (open circles) KTZ (5 mg/ml). RNA was
extracted from infected C6/36 cells at 2, 4, 8, 12, 16, 21, 24, and 27 h p.i.
and viral RNA was estimated by competitive RT-PCR.protein synthesis upon KTZ treatment is small by com-
parison with DEN-3 (approximately sevenfold; Fig. 2A),but is consistent with the lower degree of enhancement
of DEN-2 virus production in KTZ-treated C6/36 cells.
To address the possibility that viral RNA synthesis in
C6/36 cells may be stimulated by KTZ, we examined viral
RNA levels in C6/36 cells using “competitive” RT-PCR.
This method relies on the use of a “competitor” RNA
species as internal control in RT-PCR and allows quan-
titation of RNA of low abundance (12). For quantitation of
DEN-3 RNA, the competitor RNA was produced in vitro
using T3 RNA polymerase and a cloned DEN-3 cDNA
template encompassing nt 340 to 1041 of the genome of
isolate 1239 (7) with a deletion between nt 788 and nt
952. The competitor RNA was labeled with 10 nM [5,6-
3H]UTP (1.0 mCi/ml, 5 Ci/mmol; New England Nuclear
orp., Boston, MA) for quantitation by measuring 3H
ncorporation. The cDNA was then removed by digestion
ith DNase I (RQ1, Promega), and the competitor RNA
as purified by phenol/chloroform extraction and resus-
ended to 10 pg/ml in nuclease-free water for storage at
70°C. C6/36 (1 3 106) cells were infected with DEN-3
strain 1153; m.o.i. ;10) with or without KTZ treatment.
otal intracellular RNA was extracted at 2, 4, 8, 12, 16, 21,
4, and 27 h p.i. as described (13) and was resuspended
n 20 ml nuclease-free water. Each sample (1 ml) was
ixed with a 2-fold dilution series of the competitor RNA
tarting at 107 copies/ml (3 pg/ml; assuming 3.3 3 106
copies of 0.54-kb RNA per picogram) and subjected to
RT-PCR using DEN-3-specific sense primer P340 and
antisense primer P1025 (7). The products of RT-PCR were
electrophoresed on a 1% agarose gel for assessment of
relative amounts of the two cDNA products of 0.70 and
0.54 kb, derived from viral RNA and competitor RNA,
respectively. The amount of virus-specific RNA originally
present (expressed as number of copies per 106 cells in
ig. 2B) was taken to be equivalent to the amount of the
ompetitor RNA added, which resulted in identical
mounts of the two cDNA species after RT-PCR. The
esults presented in Fig. 2B show only low levels of
irus-specific RNA (2–8 3 106 copies per 106 cells) at the
early time points (2–17 h p.i.). An 8-fold increase in viral
RNA level was observed in KTZ-treated cells between 17
and 21 h p.i., this increase was not seen in untreated
cells (Fig. 2B). Viral RNA levels continued to rise in
KTZ-treated cells after 21 h p.i. There was no change in
RNA levels in untreated C6/36 cells until 27 h p.i. when a
2-fold increase was observed. Between 21 and 27 h p.i.,
KTZ increased viral RNA levels in C6/36 cells 10- to
20-fold by comparison with untreated cells. The extent
and times of increase in viral RNA synthesis correlated
broadly with infectivity titers in this experiment as the
first rise in EV titers in KTZ-treated and untreated cells
occurred at 24 h (1500 PFU/ml) and at 30 h p.i. (600
PFU/ml), respectively.
The studies presented show that KTZ has a significant
stimulatory effect on the replication of dengue viruses in
C6/36 cells. The stimulation by KTZ of replication of
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5RAPID COMMUNICATIONDEN-3 in C6/36 cells resulted in increases in virus-
specific RNA and protein synthesis and in both extracel-
lular and cell-associated virus titers. Since there was no
significant increase in numbers of cells infected when
examined at 24–30 h p.i. by IFA, the increased titers
appeared to result mainly from earlier onset of viral
replication in KTZ-treated C6/36 cells.
Enhancement of dengue replication by KTZ was not
observed in another mosquito cell line, TRA-171, derived
from T. amboinensis, or in the primate Vero and U-937
cells, suggesting that a host-specific component present
in C6/36 cells was responsible for the enhanced repli-
cation. KTZ enhanced virus production of DEN-3, DEN-2,
DEN-1 (15-fold enhancement in titers at 48 h p.i., data not
shown), and MVE viruses but not that of YFV. The 17D
vaccine strain of yellow fever virus used in this investi-
gation has been extensively passaged (more than 200
times) in tissues and cell cultures and may not be as
adaptable to efficient replication in mosquito cells. Ross
River virus, an alphavirus, showed no enhancement in
virus production following KTZ treatment of C6/36 cells
(data not shown). Hence the effect of KTZ on viral repli-
cation appears to be cell and virus specific.
The mode of action of KTZ on enhancement of flavivi-
rus replication in C6/36 cells is unknown. Given the
unchanged percentage of infected cells in KTZ treatment
and that maximal enhancement occurred when KTZ was
added within the first 4 h of virus infection, it seems
unlikely that effects on entry or uncoating of virus ac-
counted for the enhanced viral replication. Rather, viral
protein and RNA synthesis appears to be stimulated in
the presence of KTZ. It is possible that host components
interacting with the viral RNA replicase complex during
transcription and translation are affected by KTZ, and this
facilitates enhanced viral RNA synthesis. KTZ and some
related imidazole compounds inhibit the synthesis of
ergosterol in fungal membranes by blocking demethyl-
ation of the precursor lanosterol (8). At higher concen-
trations of KTZ (.2 3 1028 M), cholesterol synthesis can
lso be affected in some mammalian cells via similar
lockage of lanosterol demethylation (14). Accordingly,
TZ-induced enhancement may be the result of changes
n intracellular membrane composition, given the effects
n lipid biosynthesis of this agent at the concentrations
sed in this investigation.
A range of compounds are known to affect replication
f flaviviruses. Chemicals affecting the pH inside intra-
ellular organelles such as ammonium chloride, methyl-
mine, and chloroquine and the ATPase inhibitor bafilo-
ycin A1 are known to affect replication at the stages of
irus entry and virus maturation (15–18). It has been
eported that the fungal metabolite brefeldin A inhibits
est Nile virus replication in Vero cells due to the re-
uced glycoprotein transport from the endoplasmic re-iculum to the Golgi, but replication in C6/36 cells is not
ffected (19). However, KTZ is unique in enhancing rep-ication of flaviviruses in the mosquito C6/36 cells. We
ave examined virus particles produced from KTZ-
reated C6/36 cells and have found no difference in
igration of the viral proteins by SDS–PAGE. Also there
as no change in specific infectivity for Vero and C6/36
ells (data not shown).
The use of KTZ has practical application as a means of
mproving the efficiency of flavivirus isolation and yield of
irus in C6/36 cells. This is particularly useful for many
tudies of dengue viruses because unadapted dengue
solates often give poor yields in tissue culture, therefore
equiring extensive passaging in cell culture to obtain
irus stocks of adequate titers for laboratory investiga-
ion. The routine use of KTZ for dengue virus production
n C6/36 cells would lead to higher virus yields and may
ncrease the success rate in virus isolation.
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